These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 9639806
1. Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis. Yang X, Wang H, Zhu Z, Deng A. J Tongji Med Univ; 1997; 17(2):126-8. PubMed ID: 9639806 [Abstract] [Full Text] [Related]
2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P. Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [Abstract] [Full Text] [Related]
3. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis. Steele J, Billington T, Janus E, Moran J. Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346 [Abstract] [Full Text] [Related]
5. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. Burrell D, Antignani A, Fein PA, Goldwasser P, Mittman N, Avram MM. ASAIO Trans; 1990 Sep; 36(3):M331-5. PubMed ID: 2123635 [Abstract] [Full Text] [Related]
6. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R. Ren Fail; 2006 Sep; 28(7):567-71. PubMed ID: 17050239 [Abstract] [Full Text] [Related]
11. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Sniderman A, Cianflone K, Kwiterovich PO, Hutchinson T, Barre P, Prichard S. Atherosclerosis; 1987 Jun; 65(3):257-64. PubMed ID: 3619989 [Abstract] [Full Text] [Related]
12. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. Dieplinger H, Schoenfeld PY, Fielding CJ. J Clin Invest; 1986 Apr; 77(4):1071-83. PubMed ID: 3082933 [Abstract] [Full Text] [Related]
13. Increased activity of plasma cholesteryl ester transfer protein in children with end-stage renal disease receiving continuous ambulatory peritoneal dialysis. Asayama K, Hayashibe H, Mishiku Y, Honda M, Ito H, Nakazawa S. Nephron; 1996 Apr; 72(2):231-6. PubMed ID: 8684532 [Abstract] [Full Text] [Related]
14. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Kidney Int; 1990 Mar; 37(3):980-90. PubMed ID: 2313985 [Abstract] [Full Text] [Related]
15. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients. Fytili CI, Progia EG, Panagoutsos SA, Thodis ED, Passadakis PS, Sombolos KI, Vargemezis VA. Ren Fail; 2002 Sep; 24(5):623-30. PubMed ID: 12380908 [Abstract] [Full Text] [Related]
16. Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD. Gault MH, Longerich L, Prabhakaran V, Purchase L. ASAIO Trans; 1991 Sep; 37(3):M513-4. PubMed ID: 1751258 [Abstract] [Full Text] [Related]